Proton Pump Inhibitors Independently Protect Against Early Allograft Injury or Chronic Rejection After Lung Transplantation
ConclusionsPost-lung transplant exposure to persistent PPI therapy results in the greatest protection against rejection in lung transplant recipients, independent of other clinical predictors including BMI, suggesting that PPI may have antireflux or anti-inflammatory effects in enhancing allograft protection.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
More News: Acid Reflux | Bone Graft | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Lung Transplant | Study | Transplant Surgery | Transplants